After three years of losses, Qantas posts $1b half-year profit
Australian airline Qantas (ASX: QAN) has returned to profit after t...
NAB Ventures leads $30m Series A for payments processor DataMesh
Fintech DataMesh has today announced a $30 million Series A funding...
Salus Ventures: the new $40m fund looking to invest in sovereign capabilities
A new $40 million Sydney-based venture capital firm has hired forme...
QT, Thredbo and cinema owner EVT earnings rebound as entertainment and travel spending resumes
The company which manages a portfolio of hotels including QT, Rydge...
“Meaningfully changing lives across the world”: Startmate reveals tech-driven Summer ’23 cohort
From developing medical devices that treat depression to maturing s...
Send Payments wraps up oversubscribed $11.5m Series B raise as Europe beckons
Fintech-as-a-service company Send Payments has wrapped up an $11.5 ...
Magellan Financial shares fired up as interim profit slump clears the decks
Magellan Financial Group (ASX: MFG) has drawn a line in the sand wi...
Capturing carbon and funds: Loam Bio raises $105 million in Series B
An Australian startup using microbial technology to extend how long...
Canberra’s Quantum Brilliance closes $26m raise backed by Main Sequence, Investible and more
A quantum computing startup looking to miniaturise the futuristic t...
Credit and payments platform provider Shift closes $27m Series C
Fast-growing ‘finance on demand’ platform provider Shif...
The Star predicts up to $1.6b impairment for NSW business post-Bell Review
Costs associated with the fallout from the Bell Review of The Star&...
Mad Paws gets investor tails wagging with $4m raise
ASX-listed pet care platform Mad Paws (ASX: MPA) has today emerged ...
Fable Food Co defies global plant-based meat downturn to raise $12.2 million in Series A round
Sunshine Coast-based Fable Food Co has fended off a downturn in the...
Early-stage funding hits record high as mega-deals drop off
Despite venture capital funding falling by a third for Australian s...
Emyria, Little Green Pharma shares spike after TGA green light for MDMA and psilocybin
Alternative medicines stocks are on a tear today as investors take ...
Investors back high flying DroneShield with $11m raise
Having secured $22 million in purchase orders over the last two mon...
Atlassian losses continue despite subscription revenue growth
Australian-founded tech giant Atlassian Corporation (NASDAQ: TEAM) ...
Collection House, Wallet Wizard owner Credit Corp shares buoyant on loan book uplift
Shares in Credit Corp (ASX: CCP), the owner of Wallet Wizard, ...
Booktopia secures $12 million for Western Sydney distribution centre
Having last week revealed its plans to improve its full year earnin...
Group structure thought starters: How should mine look?
What does your corporate structure say about you? Does it showcase ...
Salesforce Ventures joins quantum tech startup Q-CTRL’s $39m Series B top up
Salesforce Ventures has this week backed a Series B-1 fundraise of ...
FoodByUs orders up $12m Series B led by Base Capital
Sydney-based wholesale hospitality marketplace FoodByUs has to...
Mighty Craft profitable as quarterly revenue nearly doubles
A listed craft beverage business that owns 10 per cent of in-admini...
Forrest family's Tattarang backs luxury fashion label CAMILLA
The private investment firm of Australian billionaire Dr Andrew ...
Zip reports record second quarter revenue as bad debt situation improves
The share of bad debts as a percentage of total transaction volume ...
Mad Paws revenue more than triples as marketplace strategy kicks into gear
Pet services platform Mad Paws’ (ASX: MPA) 'ecosystem'...
UK law firm Leigh Day serves class action against Link over $6.5b Woodford collapse
After failing in its bid to launch a combined class action against ...
Natural hydrogen company chaired by Alexander Downer, Gold Hydrogen, debuts on ASX
A company currently exploring an ‘extensive’ natural hy...
Mobile phone camera AI tech developer Acusensus set for $100m ASX debut
Melbourne-based mobile phone camera technology company Acusensus (A...
AMP Collimate sale to Dexus hits snag with Chinese regulator delay, sale price cut by $25m
A major part of AMP's (ASX: AMP) separation plans for AMP Capit...